chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Vomiting
Clinical narrative: Terrible migraines; Vomitting; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Mar2021 at 11:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021, (also reported with the start date as 10Mar2021) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 11Mar2021 at 13:00, the patient experienced terrible migraines and vomiting. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of vomiting and included treatment with unspecified pills (reported as pills for nausua). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events terrible migraines and vomiting was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Lymph node pain, Lymphadenopathy, Migraine
Clinical narrative: I was very fatigued; Had Chills; Migraine; Arm Pain; The worst reaction was the lymph node in my left armpit was incredibly swollen, about the size of an orange.; The worst reaction was the lymph node in my left armpit was incredibly swollen, about the size of an orange. It was very painful.; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 07Apr2021 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 12Mar2021 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient was very fatigued, had chills, a migraine and arm pain. The worst reaction was the lymph node in the left armpit was incredibly swollen, about the size of an orange. It was very painful. The other symptoms lasted about 2-3 days, but the swollen lymph node lasted about a week. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fatigued, had chills, a migraine, arm pain, lymph node in the left armpit was incredibly swollen, about the size of an orange and it was very painful were resolved on an unknown date in 2021.   No follow-up attempts are possible. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: I was very fatigued; Had Chills; Migraine; Arm Pain; The worst reaction was the lymph node in my left armpit was incredibly swollen, about the size of an orange.; The worst reaction was the lymph node in my left armpit was incredibly swollen, about the size of an orange. It was very painful.; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 07Apr2021 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 12Mar2021 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient was very fatigued, had chills, a migraine and arm pain. The worst reaction was the lymph node in the left armpit was incredibly swollen, about the size of an orange. It was very painful. The other symptoms lasted about 2-3 days, but the swollen lymph node lasted about a week. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fatigued, had chills, a migraine, arm pain, lymph node in the left armpit was incredibly swollen, about the size of an orange and it was very painful were resolved on an unknown date in 2021.   No follow-up attempts are possible. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass
Clinical narrative: Big hard bump where shot was administered; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Apr2021 at 15:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 08Apr2021 at 15:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 15:00, the patient experienced big hard bump where shot was administered, 4 days in and had not gone at all. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event big hard bump where shot was administered was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; This is a spontaneous report from a contactable consumer, the patient. A 36-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 10:15 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome (IBS), endometriosis, anxiety, depression,  and chickenpox. The patient previously received codeine (MANUFACTURER UNKNOWN) on an unspecified date for an unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), trazodone hydrochloride (DEPRAX), cetirizine hydrochloride (ZYRTEC), lorazepam (MANUFACTURER UNKNOWN) and dicycloverine hydrochloride (BENTYL). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021 at 08:00 the patient was diagnosed with a small case of shingles, was wrapped around her right rib cage. The patient did have chicken pox as a child so the vaccine did not gave her shingles but it may have triggered the outbreak. Therapeutic measures were taken as a result of the event which included Valtrex 3 times  for 7 days. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care The clinical outcome of the event shingles was recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Gastrooesophageal reflux disease
Clinical narrative: Had first meal following the vaccine, had non-stop acid reflux, at the point of not wanting to eat.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 26Apr2021 at 16:15 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021 at 18:00 the patient reported that after taking the first meal, followed by vaccination, had non-stop acid reflux and at the point  not wanting to eat. Therapeutic measures were taken as a result of reported events which included treatment with acid medication. Since the vaccination, the patient had not been tested for COVID-19.  The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event had non-stop acid reflux was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Hypoaesthesia
Clinical narrative: I have a pain at the back left side maybe at the back of hip; I have a pain at the back left side maybe at the back of hip; My left calf is prepared to be numb;  it would go away and come back.; This is a spontaneous report from a contactable consumer (patient). A 35-year-old female patient received second dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number: EW0173, expiration date: Aug2021, age at vaccination: 35-year-old), via an unspecified route of administration, administered in arm left on 27Apr2021 as DOSE 2, SINGLE for COVID-19 immunisation. No medical history was reported. Concomitant medications included ascorbic acid, betacarotene, calcium sulfate, colecalciferol, cyanocobalamin, ferrous fumarate, folic acid, nicotinamide, pyridoxine hydrochloride, retinol acetate, riboflavin, thiamine mononitrate, tocopheryl acetate, zinc oxide (PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE, CALCIUM SULFATE, COLECALCIFEROL, CYANOCOBALAMIN, FERROUS FUMARATE, FOLIC ACID, NICOTINAMIDE, PYRIDOXINE HYDROCHLORIDE, RETINOL ACETATE, RIBOFLAVIN, THIAMINE MONONITRATE, TOCOPHERYL ACETATE, ZINC OXIDE]) taken for an unspecified indication, start and stop date were not reported, cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for allergic, start and stop date were not reported. Previously the patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ER8737, age at vaccination: 35-year-old), in arm left on 06Apr2021 for COVID-19 immunization. No investigation assessment. The patient reported that she was calling and was not sure if it was related to the vaccine. She got the vaccine on Tuesday that was 27Apr2021 and then two days after Thursday (29Apr2021) she started having like her left calf was prepared to be numb, it would go away and come back. It started happening Thursday afternoon and then Friday too and then it went away but since yesterday (02May2021) afternoon she have like a pain at the back left side maybe at the back of her hip. There was no numbness right now but pain on the left side I think back of my hip. No treatment was received for the events. She was not like that and was not sure if those related or just going to the answer related to the vaccine. So, she was calling hopefully to find some answers. Consumer was informed about Pfizer Medical Information Department. The outcome of event my left calf was prepared to be numb, it would go away and come back was recovered on an unknown date in 2021 and outcome of other events was not recovered.  No follow-up attempts are needed. No further information was expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Heart rate abnormal
Clinical narrative: Heart/pulse racing; This is a spontaneous report from a Contactable consumer. This 58-years-old female consumer (patient) reported for herself that who received first dose of BNT162B2 (BNT162B2, solution for injection), via an unspecified route of administration, administered in Arm Right on 05Apr2021 (Batch/Lot Number: ER8734) as SINGLE for covid-19 immunization and was administered in Pharmacy/Drug Store. Medical history included obesity from an unknown date and unknown if ongoing and ongoing anxiety has been taking it off and on for years. Concomitant medication included acetylsalicylic acid (ASPIRIN) 81 mg, as needed taken for anxiety from an unspecified start date and ongoing. She has had an EKG (electrocardiogram) years ago for anxiety. Prior Vaccinations (within 4 weeks) was reported as none. Family medical history relevant to AE(s) was reported as none. Relevant tests as none. Caller has received the first dose of the Covid-19 vaccine. 12 hours later after receiving the vaccine and the next day on 06Apr2021, her heart/pulse was racing on and off. She was due to get the second dose today. She was a little nervous about getting it. She understood the side effects that may happen. She does not know if this was a normal side effect. The patient underwent lab tests and procedures which included electrocardiogram anxiety. The outcome of event was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Vaccination site erythema, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: 24 hours after 2nd vaccine intermittent numbness to right arm; Swelling, redness, pain and warmth at injection site; Swelling, redness, pain and warmth at injection site.; Swelling, redness, pain and warmth at injection site.; Swelling, redness, pain and warmth at injection site.; This is a spontaneous report from a contactable nurse, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the right arm on 30Apr2021 at 19:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included attention deficit-hyperactivity disorder (ADHD) and anxiety. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lisdexamfetamine mesilate (VYVANSE), sertraline hydrochloride (ZOLOFT), hydroxyzine (MANUFACTURER UNKNOWN) and vitamin d nos (VITAMIN D); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 04Apr2021 at 10:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 at 22:00, 24 hours after second vaccine, the patient experienced intermittent numbness to right arm, swelling, redness, pain and warmth at injection site. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with ibuprofen and ice. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events numbness to right arm, swelling, redness, pain and warmth at injection site was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Muscle spasms, Neuralgia, Petechiae
Clinical narrative: Unexplained bruising; petechiae on torso/chest/left arm; muscle spasms; nerve pain; This is a spontaneous report from a contactable consumer, the patient. A 36-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Apr2021 at 12:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine, GERD and allergy to kiwi. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) and paracetamol (ACETAMINOPHEN); both from an unknown date, for unknown indication and unknown if ongoing. On 30Apr2021 at 17:00, the patient experienced unexplained bruising, petechiae on torso/chest/left arm, muscle spasms and nerve pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events unexplained bruising, petechiae on torso/chest/left arm, muscle spasms and nerve pain was not recovered at the time of this report.   No follow-up attempts are required; information about lot number cannot be obtained. No further information is expected.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Developed shingles on the 3rd week after getting the first shot; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the arm left on an unknown date in Apr2021 at 14:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history of the patient was not reported. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had other unspecified medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient developed shingles on the 3rd week after getting the first shot. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event developed shingles on the 3rd week after getting the first shot was resolving at the time of reporting.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Palpitations
Clinical narrative: Hard pounding heartbeat that is not irregular or fast; dizziness; exhaustion; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 28Apr2021 at 12:45 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included Graves' disease, but the patient was in remission since 2018. The patient had no known allergies. Concomitant medications included daily supplemental vitamins (MANUFACTURER UNKNOWN), taken for an unspecified indication for an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 01Apr2021 at 10:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 22:00, the patient experienced hard pounding heartbeat that was not irregular or fast, which seemed to be causing dizziness and exhaustion. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events hard pounding heartbeat, dizziness and exhaustion were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dizziness, Fatigue, Feeding disorder, Headache
Clinical narrative: nausea (actually vomited); nausea (actually vomited); couldn't eat; fever of 102; extreme fatigue; dizziness; headache; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 40-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EW0182) via unknown route of administration on 01May2021 at 4 pm dose 2, single on left arm (age at vaccination: 40 years) for Covid-19 immunisation. The patient's medical history was none. Patent did not have covid-prior vaccination and did not tested covid post vaccination. Patient had no known allergies. The concomitant medications included "multivitamin", colecalciferol (VITAMIN D) and zinc. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EW0153) via unknown route of administration on 10Apr2021 at 4 pm dose 1, single on left arm for Covid-19 immunisation and experienced slight arm pain and fatigue for 24 hrs. The patient reported that the second dose gave me nausea (actually vomited), couldn't eat, fever of 102, extreme fatigue, dizziness, headache; all from 01May2021 at 9 pm for about a day and a half. It was extreme- no it didn't last long but I felt a little misled, it has been two days and the headache is still strong, but the other effects have diminished. Patient did not receive treatment for the events. The outcome of the events headache was not resolved, and all other events was resolving.  No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vomiting
Clinical narrative: nausea (actually vomited); nausea (actually vomited); couldn't eat; fever of 102; extreme fatigue; dizziness; headache; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 40-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EW0182) via unknown route of administration on 01May2021 at 4 pm dose 2, single on left arm (age at vaccination: 40 years) for Covid-19 immunisation. The patient's medical history was none. Patent did not have covid-prior vaccination and did not tested covid post vaccination. Patient had no known allergies. The concomitant medications included "multivitamin", colecalciferol (VITAMIN D) and zinc. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EW0153) via unknown route of administration on 10Apr2021 at 4 pm dose 1, single on left arm for Covid-19 immunisation and experienced slight arm pain and fatigue for 24 hrs. The patient reported that the second dose gave me nausea (actually vomited), couldn't eat, fever of 102, extreme fatigue, dizziness, headache; all from 01May2021 at 9 pm for about a day and a half. It was extreme- no it didn't last long but I felt a little misled, it has been two days and the headache is still strong, but the other effects have diminished. Patient did not receive treatment for the events. The outcome of the events headache was not resolved, and all other events was resolving.  No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Raynaud's phenomenon
Clinical narrative: Fingers lost feeling on a 50 degree day; Diagnosed with Raynaud's disease; This is a spontaneous report from a contactable consumer (patient). A 46-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was unknown), dose 2 via an unspecified route of administration, administered in Arm Left on 27Apr2021 09:15 (at the age of 46-year-old) as dose 2, single for COVID-19 immunization. Medical history included known allergy: penicillin, cortisone class b from an unknown date and unknown if ongoing and other medical history was none reported. Concomitant medication(s) included spironolactone taken for an unspecified indication, start and stop date were not reported (other medications in two weeks). The patient previously received first dose of BNT162B2 (Lot number: unknown), via an unspecified route of administration, administered in Arm Left on 30Mar2021 9:30 AM (at the age of 46-year-old) for COVID-19 immunization. The patient did not receive other vaccines in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient had not been tested for COVID-19. On 05May2021 17:00, patient experienced fingers lost feeling on a 50 degree day, diagnosed with raynaud's disease. Patient visited doctor or other healthcare professional office/clinic for adverse events. There was no treatment for the events. The outcome of events was recovered with sequelae on an unspecified date in 2021.  No follow up attempts are possible. Information on lot/batch number cannot be obtained.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Nausea
Clinical narrative: Dizziness; Nausea; Headache; Fever; Chills; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0170) via an unspecified route of administration in the left arm on 02May2021 at 11:15 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included systemic lupus erythematosus (SLE). The patient has allergy to penicillin and blueberries. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021 at 02:00 the patient experienced nausea, headache, dizziness, fever, chills and fatigue. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, headache, dizziness, fever, chills and fatigue were not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Dizziness; Nausea; Headache; Fever; Chills; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0170) via an unspecified route of administration in the left arm on 02May2021 at 11:15 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included systemic lupus erythematosus (SLE). The patient has allergy to penicillin and blueberries. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021 at 02:00 the patient experienced nausea, headache, dizziness, fever, chills and fatigue. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, headache, dizziness, fever, chills and fatigue were not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Headache, Neck pain, Pain in extremity, Peripheral swelling
Clinical narrative: Experienced head about 12 hoursafter shot that lasted 24hour; Currently Left arm is red swollenpainful and itching around the injection; Currently Left arm is red swollenpainful and itching around the injection; Currently Left arm is red swollenpainful and itching around the injection; Currently Left arm is red swollenpainful and itching around the injection; Neck and arm pain on the left side; This is a spontaneous report from a contactable healthcare professional, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 30Apr2021 at 12:00  as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 12Apr2021 at 12:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19.. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 at 00:00, the patient experienced currently left arm is red swollen, painful and itching around the injection site nearly 72 hours after the shot, neck and arm pain on the left side experienced head about 12 hours after shot, that lasted 24hours. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the events  redness, painful and itching around the injection site, neck , arm pain on the left side and headache were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: Experienced head about 12 hoursafter shot that lasted 24hour; Currently Left arm is red swollenpainful and itching around the injection; Currently Left arm is red swollenpainful and itching around the injection; Currently Left arm is red swollenpainful and itching around the injection; Currently Left arm is red swollenpainful and itching around the injection; Neck and arm pain on the left side; This is a spontaneous report from a contactable healthcare professional, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 30Apr2021 at 12:00  as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 12Apr2021 at 12:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19.. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 at 00:00, the patient experienced currently left arm is red swollen, painful and itching around the injection site nearly 72 hours after the shot, neck and arm pain on the left side experienced head about 12 hours after shot, that lasted 24hours. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the events  redness, painful and itching around the injection site, neck , arm pain on the left side and headache were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Menstruation irregular, Pain in extremity, Pyrexia
Clinical narrative: Feverish; hot flashes; arm and leg pain; period started the next day (though it wasnt due for a week); This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EC6818) via an unspecified route of administration in the left arm on 29Apr2021 at 12:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8731) via an unspecified route of administration in the left arm on 01Apr2021 at 12:15 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 30Apr2021 at 02:00, the patient felt feverish, hot flashes, arm and leg pain and period started the next day (though it wasn't due for a week). The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events feverish, hot flashes, arm and leg pain and period started the next day (though it wasn't due for a week) were unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: axillary lymph node swollen to about the size of tennis ball in right arm; This is a spontaneous report from a contactable healthcare professional, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the right arm on 01May2021 at 13:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no known allergies to medications, food, or other products. It was not reported if the patient received any medication within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 10Apr2021 at 14:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021 at 09:00, the patient experienced axillary lymph node swollen to about the size of tennis ball in right arm. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event axillary lymph node swollen to about the size of tennis ball in right arm was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Lymphadenopathy, Pyrexia
Clinical narrative: fever; chills; lower back pain; swollen lymph nodes under arms; This is a spontaneous report from a non-contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 01May2021 at 09:45 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 03Apr2021 at 10:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021, the patient experienced fever, chills, lower back pain and swollen lymph nodes under arms. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse events reported. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, lower back pain and swollen lymph nodes under arms were resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain in left arm; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 10:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. The patient did not receive any medication within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 13:00, the patient experienced pain in left arm. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event pain in left arm was resolved on an unknown date in 2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Facial pain, Fatigue, Headache, Illness
Clinical narrative: I had a splitting headache; The top of my head heart it was a major headache not like the migraine; My face hurt; even my back hurt; My face hurt; even my back hurt; I started feeling really sick; I still feel washed out and tired; today I got sick again; Then I got a stiff neck and the lower back hearts then I got nausea; Then I got a stiff neck and the lower back hearts then I got nausea; This is a spontaneous report from a contactable consumer. This 79-year-old female consumer (patient herself) reported that patient received bnt162b2 (BNT162B2, Formulation was Solution for injection, Lot Number was not reported), via unspecified route on an unspecified date dose number unknown, single, as single dose for COVID-19 immunization. The patient's medical history included Diabetes and Non-alcoholic Cirrhosis and concomitant medications were not reported. On an unspecified date the patient had a splitting headache, the top of her head heart it was a major headache not like the migraine, the top of her head hurt, forehead hurt; across the bridge of her nose hurt like mad, her face hurt, even her back hurt, she started feeling really sick, she still feels washed out and tired, today she got sick again and Then she got a stiff neck and the lower back hearts then got nausea. Treatment received as she took anti-nausea medicines, she took extra strength acetaminophen, then she used ice pack for her headache and a heating pad for the neck, then she took one pill for joint pain for the neck and lower back. Probably not be able to pronounce it, Meloxicam 7.5 mg the Meloxicam. The outcome of all events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Nausea
Clinical narrative: I had a splitting headache; The top of my head heart it was a major headache not like the migraine; My face hurt; even my back hurt; My face hurt; even my back hurt; I started feeling really sick; I still feel washed out and tired; today I got sick again; Then I got a stiff neck and the lower back hearts then I got nausea; Then I got a stiff neck and the lower back hearts then I got nausea; This is a spontaneous report from a contactable consumer. This 79-year-old female consumer (patient herself) reported that patient received bnt162b2 (BNT162B2, Formulation was Solution for injection, Lot Number was not reported), via unspecified route on an unspecified date dose number unknown, single, as single dose for COVID-19 immunization. The patient's medical history included Diabetes and Non-alcoholic Cirrhosis and concomitant medications were not reported. On an unspecified date the patient had a splitting headache, the top of her head heart it was a major headache not like the migraine, the top of her head hurt, forehead hurt; across the bridge of her nose hurt like mad, her face hurt, even her back hurt, she started feeling really sick, she still feels washed out and tired, today she got sick again and Then she got a stiff neck and the lower back hearts then got nausea. Treatment received as she took anti-nausea medicines, she took extra strength acetaminophen, then she used ice pack for her headache and a heating pad for the neck, then she took one pill for joint pain for the neck and lower back. Probably not be able to pronounce it, Meloxicam 7.5 mg the Meloxicam. The outcome of all events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: U
Vaccine: COVID19
Symptoms: Cardiac disorder
Clinical narrative: heart include flashes really bad which is; This is a spontaneous report from a contactable consumer. This consumer (Patient) of unspecified age and gender reported that the patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number/Expiry Date: Unknown), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient called because it said on form to relate any type of possible side effect, so they know that the patient had been kind of waiting in a doubt to see and then also figure out what was going on, it was been crazy busy here for the patient. So the patient had heart include flashes which was really bad. The patient wanted to know if that was a normal side effect or not. The outcome of event was unknown.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Hypoaesthesia, Neuralgia
Clinical narrative: Numbness from the arm to head and neuralgia occurred; Numbness from the arm to head and neuralgia occurred; Discomfort; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 38-year-old (non-pregnant) female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN0178) via an unspecified route of administration, administered in arm left on 24Apr2021 14:00 (at the age of 38-year-old) at dose 1, single for covid-19 immunisation. Medical history and concomitant medications were not reported. Patient did not have known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 24Apr2021 14:00 the patient experienced numbness from the arm to head and neuralgia occurred, discomfort. As soon as the vaccine was administered on the left arm, there was numbness from the arm to head, and neuralgia occurred. At the time of this reporting, there was neuralgia from head to end of foot only on the left side. It was not as much that normal life was impossible but there was discomfort. Patient did not receive treatment for the adverse events. Outcome of the events was resolving.    No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Electrocardiogram
Clinical narrative: Chest pain; This is a spontaneous report from a contactable consumer or other non hcp (patient reported for herself). A 55-year-old adult female patient (non-pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EW0167), dose 1 via an unspecified route of administration, administered in Arm Left on 06May2021 at 12:15 PM (at the age of 55-year-old) as DOSE 1, SINGLE for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Patient other medical history was none. The patient had no covid prior vaccination. The patient known allergies were none. The patient concomitant medication(s) included Paracetamol (TYLENOL) taken for an unspecified indication, start and stop date were not reported. No other vaccine in four weeks. The patient had not been covid tested post vaccination. On 06May2021 at 12:15 PM after the vaccination, the patient experienced chest pain. The patient underwent lab tests and procedures which included EkG (electrocardiogram): result unknown on an unspecified date in 2021. Unspecified therapeutic measures were taken as a result of chest pain. The patient outcome of the event was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.